Access Resources
1211 - 1220 of 7540 Results
Title
Year
- Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's disease2022RESTRICTEDTitle: Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 75End Page: 89Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.013Best OA location URL: http://www.prd-journal.com/article/S1353802022002048/pdfCitation Count: 5
- PLA2G6-associated neurodegeneration in four different populations-case series and literature review2022RESTRICTEDTitle: PLA2G6-associated neurodegeneration in four different populations-case series and literature reviewJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 66End Page: 74Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.016Best OA location URL: http://manuscript.elsevier.com/S1353802022002115/pdf/S1353802022002115.pdfCitation Count: 4
- Protein interaction network analysis reveals genetic enrichment of immune system genes in frontotemporal dementia2022RESTRICTEDTitle: Protein interaction network analysis reveals genetic enrichment of immune system genes in frontotemporal dementiaJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 116Issue #:Start Page: 67End Page: 79Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2022.03.018Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2022.03.018Citation Count: 2
-
RESTRICTEDTitle: Racial disparities in hypertension management among multiple sclerosis patientsJournal Name: Multiple Sclerosis and Related DisordersPublisher: Elsevier BVVol: 64Issue #:Start Page: 103972End Page: 103972Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.msard.2022.103972Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308758Citation Count: 7
- Relationships of self-reported and objective measures of sleep, sleepiness, and sleep quality in Parkinson's disease2022RESTRICTEDTitle: Relationships of self-reported and objective measures of sleep, sleepiness, and sleep quality in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 57End Page: 61Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.009Best OA location URL: http://manuscript.elsevier.com/S1353802022001924/pdf/S1353802022001924.pdfCitation Count: 3
- Reply to: “Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations”?2022RESTRICTEDTitle: Reply to: “Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations”?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1782End Page: 1782Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29136Citation Count: 0
- Reply to: “Overlapping Ranges in Levels Indicate That Hexosylsphingosine Is Not a Clinically Relevant Biomarker for GBA1‐Associated Parkinson's Disease”2022RESTRICTEDTitle: Reply to: “Overlapping Ranges in Levels Indicate That Hexosylsphingosine Is Not a Clinically Relevant Biomarker for GBA1‐Associated Parkinson's Disease”Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1781End Page: 1782Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29131Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756875Citation Count: 0
- Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonism2022RESTRICTEDTitle: Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonismJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 39End Page: 42Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.019Citation Count: 0
-
RESTRICTEDTitle: Table for OneJournal Name: Brain & LifePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 18Issue #: 4Start Page: 30End Page: 32Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nnn.0000856280.92010.9bCitation Count: 0
- Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of parkinsonism2022RESTRICTEDTitle: Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of parkinsonismJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 182Issue #:Start Page: 106338End Page: 106338Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.phrs.2022.106338Best OA location URL: http://manuscript.elsevier.com/S1043661822002833/pdf/S1043661822002833.pdfCitation Count: 2